Dr. Enduo Qiu 邱恩铎
Chief Physician
Department of Bone and Soft Tissue Tumors, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Limb-salvage surgery, minimally invasive resection and reconstruction for bone tumors, neoadjuvant chemotherapy for osteosarcoma, comprehensive treatment of soft tissue sarcoma and melanoma, surgical management of bone metastases, and reconstructive repair for skin malignancies.
Dr. Qiu is a Chief Physician, team leader, and master’s supervisor. Dr. Qiu holds a master’s degree in orthopedic surgery from China Medical University.
Professional roles
- Member, Bone and Soft Tissue Tumor Professional Committee, China Medical Education Association
- Director, Bone Tumor Branch, Liaoning Society of Cell Biology
- Member, Traumatic Orthopedics Branch, Liaoning Society of Cell Biology
- Member, Digital Memory Surgery Professional Committee, Liaoning Society of Cell Biology
Name order: in Chinese the family name comes first (Qiu Enduo). Papers usually list the name as Enduo Qiu or Qiu E.
Selected publications
18 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Bioeng Biotechnol, 2023 (first author): PLGA-based drug delivery systems in treating bone tumors. PubMed 37324432
- Am J Transl Res, 2020 (first author): Upregulation of cell division cycle 20 in cisplatin resistance-induced epithelial-mesenchymal transition in osteosarcoma cells. PubMed 32355543
- Biomed Pharmacother, 2017 (senior author): SPOCK1 promotes the growth of Osteosarcoma cells through mTOR-S6K signaling pathway. PubMed 28869894
- Int J Clin Exp Pathol, 2017 (senior author): Osteosarcoma cells induce differentiation of mesenchymal stem cells into cancer associated fibroblasts through Notch and Akt signaling pathway. PubMed 31966700
- Saudi J Biol Sci, 2017 (senior author): Protection of oxidative stress induced apoptosis in osteosarcoma cells by dihydromyricetin through down-regulation of caspase activation and up-regulation of BcL-2. PubMed 28490955
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion